Publications and communications of Georges Fillet

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.

Willemze, R., Suciu, S., Meloni, G., Labar, B., Marie, J.-P., Halkes, C., Muus, P., Mistrik, M., Amadori, S., Specchia, G., Fabbiano, F., Nobile, F., Sborgia, M., Camera, A., Selleslag, D., Lefrère, F., Magro, D., Sica, S., Cantore, N., ... de Witte, T. (2014). High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial. Journal of Clinical Oncology, 32 (3), 219-228. doi:10.1200/JCO.2013.51.8571

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552

de Leval, L., BONNET, C., Copie-Bergman, C., SEIDEL, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. Annals of Oncology. doi:10.1093/annonc/mds150

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T. J., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinc clinicopathologic features: a GELA study. Annals of Oncology, 23(12), 3143-3151.

Labar, B., Suciu, S., Willemze, R., Muus, P., Marie, J. P., Fillet, G., Berneman, Z., Jaksic, B., Feremans, W., Bron, D., Sinnige, H., Mistrik, M., Vreugdenhil, G., de Bock, R., Nemet, D., Gilotay, C., Amadori, S., & De Witte, T. (2010). Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma : final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group. Haematologica, 95, 1489-1495. doi:10.3324/haematol.2009.018580

Willems, E.* , Baron, F.* , Seidel, L., Frère, P., Fillet, G., & Beguin, Y. (2010). Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 689-693. doi:10.1038/bmt.2009.230
* These authors have contributed equally to this work.

Collignon, J., Gennigens, C., Rorive, A., Coucke, P., Lifrange, E., Maweja, S., Fillet, G., & Jerusalem, G. (May 2009). ANTICORPS MONOCLONAUX ET CANCER DU SEIN: Actualités thérapeutiques. Revue Médicale de Liège, 64 (5-6), 279-83.

Baron, F., WILLEMS, E., LECHANTEUR, C., BAUDOUX, E., Frere, P., Vanbellinghen, J., Bruck, F., Gothot, A., HAFRAOUI, K., Fillet, G., & Beguin, Y. (2009). Co-transplantation of mesenchymal stem cells might mitigate acute GvHD without abrogating graftversus- tumour alloreactivity after allogeneic transplantation with non-myeloablative conditioning [Paper presentation]. 35th EBMT Annual Meeting.

Beguin, Y., Maertens, J., DE PRIJCK, B., Schots, R., Frère, P., Bonnet, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., LEJEUNE, M., SERVAIS, S., THeunissen, K., Fillet, G., & Baron, F. (2009). A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation [Poster presentation]. 24th General Meeting of the Belgian Hematological Society, Oostende, Belgium.

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.

Mievis, C., Jansen, N., Schleich, F., Gennigens, C., Rorive, A., Jerusalem, G., Fillet, G., & Sautois, B. (2009). Le cas clinique du mois. Reaction de rappel d'irradiation induite par l'administration de cyclophosphamide. Revue Médicale de Liège, 64 (4), 179-81.

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248
* These authors have contributed equally to this work.

Coucke, P., Barthelemy, N., Hustinx, R., & Fillet, G. (2008). Risk adaptive treatment in Hodgkin's lympoma: reduction of radiation dose and irradiated volume. Belgian Journal of Medical Oncology, 2 (2), 85-97.

Coudert, B., Focan, C., Genet, D., Giacchetti, S., Cvickovic, F., Zambelli, A., Fillet, G., Chollet, P., Amoroso, D., Van Der Auwera, J., Lentz, M. A., Marreaud, S., Baron, B., Gorlia, T., Biville, F., & Lévi, F. (2008). A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients : eortc trial 05971. Chronobiology International, 25, 680-696. doi:10.1080/07420520802384036

de Leval, L., Bonnet, C., Brière, J., Molina, T., Petrella, T., Bosq, J., Falini, B., Gisselbrecht, C., Reyes, F., Fillet, G., & Gaulard, P. (2008). Diffuse large B-cell lymphoma (DLBCL) of the waldeyer'ring (WR) frequently have a GC-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annals of Oncology, 13(suppl 4), 366.

Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63.

Paulus, A., Gennigens, C., Fillet, G., Loly, C., & Sautois, B. (September 2007). Traitement chimiothérapique actuel du cancer de l'ovaire. Revue Médicale de Liège, 62 (9), 539-47.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T. J., Thieblemont, C., Ferme, C., Quesnel, B., Brassiene, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (01 March 2007). CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de I'Adulte. Journal of Clinical Oncology, 25 (7), 787-792. doi:10.1200/JCO.2006.07.0722

Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x

Bonnet, C., & Fillet, G. (2007). How can we determine the role of radiotherapy in the treatment of localized aggressive non Hodgkin's lymphoma? Journal of Clinical Oncology, 25/n°19, 2857-2858.

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Falini, B., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse large B-cell lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annual Meeting Abstracts, 110, 1561.

de Leval, L., Bonnet, C., Copie-Bergmann, C., Seidel, L., Brière, J., Molina, T., Fabiani, B., Brunangelo, F., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse Large B-cell Lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Blood.

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.

Gennigens, C., Sautois, B., Rorive, A., Fillet, G., & Jerusalem, G. (2007). Actualites therapeutiques en oncologie: l'essor des therapeutiques ciblees. Revue Médicale de Liège, 62 (5-6, May-Jun), 391-8.

Jerusalem, G., Rorive, A., Gennigens, C., Sautois, B., Mievis, C., & Fillet, G. (2007). Actualités thérapeutiques en oncologie sénologique: place actuelle et perspectives des traitements cibles. Revue Médicale de Liège, 62 Spec No, 2-5.

Labar, B., Suciu, S., Muus, P., Willemze, R., Marie, J. P., Fillet, G., Berneman, Z., Jaksic, B., Feremans, W., Bron, D., Sinnige, H., Mistrik, M., Vreugdenhil, G., De Bock, R., Nemet, D., Gilotay, C., Amadori, S., & de Witte, T. (2007). Stem cell transplantation in ALL : a donor versus no donor comparison in the EORTC ALL-4 study. Leukemia Research. doi:10.1016/S0145-2126(07)70272-2

Monville, J.-F., Fillet, G., & Ghaye, B. (2007). Thoracic Extramedullary Hematopoiesis Secondary to Enzymatic Deficiency. JBR-BTR, 90 (3, May-Jun), 198-9.

Bonnet, C., Beguin, Y., FASSOTTE, M.-F., & Fillet, G. (2006). Limited usefulness of CA 125 measurement in the management of hodgkin's and non-hodgkin's lymphomas [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (January 2006). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressie lymphoma: final results of the LNH 93-4 GELA Study [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Ferme, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2006). No role for chemoradiotherapy compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255

Frere, P., Pereira-Martins, M., Fillet, G., & Beguin, Y. (2006). Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. European Journal of Haematology, 76 (2), 102-8. doi:10.1111/j.1600-0609.2005.00569.x

Jehn, U., Suciu, S., Thomas, X., Lefrère, F., Muus, P., Berneman, Z., Marie, J.-P., Adamo, F., Fillet, G., Nobile, F., Ricciuti, F., Leone, G., Rizzoli, V., Montanaro, M., Beeldens, F., Fazi, P., Mandelli, F., Willemze, R., de Witte, T., & Amadori, S. (2006). Non-infusional vs intravenous consolidation chemotherapy in eldery patients with acute myeloid leukemia : final results of th EORTC-GIMAMA AML-13 randomized phase III trial. Leukemia, 20, 1723-1730. doi:10.1038/sj.leu.2404356

Pierard, C., Pierard, G., Quatresooz, P., Arrese Estrada, J., Rorive, A., & Fillet, G. (2006). Hic et Nunc. Naevus ou melanome? Revue Médicale de Liège, 61 (1), 43-7.

Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012

Vanstraelen, G., Frere, P., Ngirabacu, M.-C., Willems, E., Fillet, G., & Beguin, Y. (2006). Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology, 34 (3), 382-8. doi:10.1016/j.exphem.2005.11.013

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2006). Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial [Paper presentation]. 21st General Meeting of the Belgian Hematological Society.

Amadori, S., Suciu, S., Jehn, U., Stasi, R., Thomas, X., Marie, J.-P., Muus, P., Lefrère, F., Berneman, Z., Fillet, G., Denzlinger, C., Willemze, R., Leoni, P., Leone, G., Casini, M., Ricciuti, F., Vignetti, M., Beeldens, F., Mandelli, F., & de Witte, T. (2005). Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia : final results of AML-13, a randomized phase-3 study. Blood, 106, 27-34. doi:10.1182/blood-2004-09-3728

Farcy, L., Fillet, G., Couvreur, V., & Triffaux, J.-M. (2005). L'anémie par spoliation sanguine volontaire : le syndrome de Lasthénie de Ferjol. Revue Médicale de Liège, 60 (9), 719-723.

Fillet, G., Bonnet, C., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2005). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study. Blood, 106 (15).

Fillet, G., Bonnet, C., Mounier, N., Ganem, N., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes. (2005). No advantage of chemoradiotherapy over chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: results of the LNH93-4 GELA study. Annals of Oncology, 16 (suppl 5).

Vanstraelen, G., Baron, F., Frere, P., Hafraoui, K., Fillet, G., & Beguin, Y. (2005). Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation. Haematologica, 90 (9), 1269-70.

Wauters, O., Sautois, B., & Fillet, G. (2005). L'image du mois. Une image de "lâcher de ballons" à l'imagerie thoracique. Revue Médicale de Liège, 60, 909.

Willems, E., Baron, F., Vanstraelen, G., Frere, P., Fillet, G., & Beguin, Y. (2005). Immunotherapie du cancer par minigreffe de cellules souches hematopoietiques. Revue Médicale Suisse, 1 (30), 1973-7.

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075).

Labar, B., Suciu, S., Zittoun, R., Muus, P., Marie, J.-P., Fillet, G., Peetermans, M., Stryckmans, P., Willemze, R., Feremans, W., Jaksic, B., Bourhis, J.-H., Burghouts, J.-P., & De Witte, T. (July 2004). Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <= 50 years old in first complete remission: results of the EORTC ALL-3 trial. Haematologica, 89 (7), 809-817.

Polus, M., Piront, P., Jerusalem, G., Sautois, B., Defechereux, T., de Leval, L., & Fillet, G. (February 2004). L'image du mois. Tumeur de Merkel : reponse majeure a la chimiotherapie. "Il n'y a pas que la neige qui fond au soleil". Revue Médicale de Liège, 59 (2), 67-8.

Frere, P., Hermanne, J.-P., Debouge, M.-H., De Mol, P., Fillet, G., & Beguin, Y. (2004). Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplantation, 33 (7), 745-9. doi:10.1038/sj.bmt.1704414

Gillain, S., Gennigens, C., Sautois, B., Polus, M., Bonnet, C., Fillet, G., & Jerusalem, G. (2004). Traitement du cancer du sein chez la personne âgée. Revue Médicale Suisse, 62, 1618-21.

Polus, M., Piront, P., Jerusalem, G., Sautois, B., Louis, E., Detroz, B., Laurent, S., Belaiche, J., & Fillet, G. (April 2003). Prevention primaire et secondaire du cancer colorectal. Revue Médicale de Liège, 58 (4), 247-53.

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220

Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80.

Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7.

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion. British Journal of Haematology, 123 (1), 103-5. doi:10.1046/j.1365-2141.2003.04556.x

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. Clinical Cancer Research, 9 (15), 5566-72.

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7

Bonnet, C., Fillet, G., Bosly, A., Van Hoof, A., Offner, F., Van Den Neste, E., DE PRIJCK, B., Deflandre, A., Gisselbrecht, C., & Reyes, F. (2003). Radiotherapy is unnecessary in elderly patients with localized aggressive non hodgkin's lymphoma: results of the LNH 93-4 study [Paper presentation]. 18th General Meeting of the Belgian Hematological Society, Brussels, Belgium.

Hafraoui, K., Humblet-Baron, S., Baron, F., Beguin, Y., & Fillet, G. (2003). Comment je traite ... la leucemie myeloide chronique (LMC). Revue Médicale de Liège, 58 (1), 7-12.

Keating, S., Suciu, S., de Witte, T., Zittoun, R., Mandelli, F., Belhabri, A., Amadori, S., Fibbe, W., Gallo, E., Fillet, G., Varet, B., Meloni, G., Hagemeijer, A., Fazi, P., Solbu, G., & Willemze, R. (January 2003). The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia, 17 (1), 60-67. doi:10.1038/sj.leu.2402782

Tilly, H., Lepage, E., Coiffier, B., Blanc, M., Herbrecht, R., Bosly, A., Attal, M., Fillet, G., Guettier, C., Jo Molina, T., Gisselbrecht, C., & Reyes, F. (2003). Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. Blood, 102 (13), 4284-4289. doi:10.1182/blood-2003-02-0542

Pelerin, D., Silvestre, R. M., Jerusalem, G., Sautois, B., Polus, M., & Fillet, G. (December 2002). Comment je traite ... par hormonotherapie des patientes developpant des complications thrombo-emboliques lors du traitement d'un cancer du sein par tamoxifene. Revue Médicale de Liège, 57 (12), 755-6.

Polus, M., Honore, P., De Roover, A., Detry, O., Detroz, B., Jerusalem, G., Sautois, B., & Fillet, G. (December 2002). La carcinomatose hepatique du cancer colorectal: actualites therapeutiques. Revue Médicale de Liège, 57 (12), 771-8.

Polus, M., Bours, V., Jerusalem, G., Sautois, B., & Fillet, G. (July 2002). Comment je traite.... Le cancer avance du pancreas par une approche innovante dirigee contre les nouvelles cibles. Revue Médicale de Liège, 57 (7), 428-32.

Gisselbrecht, C., Lepage, E., Molina, T., Quesnel, B., Fillet, G., Lederlin, P., Coiffier, B., Tilly, H., Gabarre, J., Guilmin, F., Hermine, O., & Reyes, F. (15 May 2002). Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. Journal of Clinical Oncology, 20 (10), 2472-2479. doi:10.1200/JCO.2002.02.125

Polus, M., Jerusalem, G., Sautois, B., Silvestre, R. M., & Fillet, G. (March 2002). Comment je traite.... Un cancer du pancreas avance. Revue Médicale de Liège, 57 (3), 131-4.

Polus, M., Jerusalem, G., Sautois, B., Silvestre, R. M., Collette, M. Y., Closon, M. T., & Fillet, G. (February 2002). Etude clinique du mois. Radio-chimiotherapie et chimiotherapie adjuvante apres resection a visee curative du cancer du pancreas: resultats de l'etude randomisee ESPAC-1. Revue Médicale de Liège, 57 (2), 119-22.

Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484

Baron, F., Fillet, G., & Beguin, Y. (2002). Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation. Transplantation, 74 (12), 1692-6. doi:10.1097/00007890-200212270-00008

Baron, F., Frere, P., Herens, C., Fillet, G., & Beguin, Y. (2002). Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. Haematologica, 87 (12), 43.

Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6

Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88.

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Annals of Oncology, 13 (suppl 2), 27.

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A. M., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Blood, 100 (11), 92.

Frere, P., Hermanne, J.-P., Debouge, M.-H., Fillet, G., & Beguin, Y. (2002). Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation, 29 (7), 589-94. doi:10.1038/sj/bmt/1703413

Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84.

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2001). Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571. Haematologica, 86 (9), 993-4.

Boogaerts, M., Maertens, J., van Hoof, A., de Bock, R., Fillet, G., Peetermans, M., Selleslag, D., Vandercam, B., Vandewoude, K., Zachée, P., & De Beule, K. (2001). Intraconzole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients. Journal of Antimicrobial Chemotherapy, 48, 97-103. doi:10.1093/jac/48.1.97

Bosly, A., Lepage, E., Coiffier, B., Fillet, G., Herbrecht, R., Divine, M., Dupriez, B., Nouvel, C., Deconninck, E., Tilly, H., Bordessoule, D., Gaulard, P., & Gisselbrecht, C. (2001). Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma. Hematology Journal, 2, 279-285. doi:10.1038/sj.thj.6200116

Fillet, G., & Beguin, Y. (2001). Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietin. Acta Clinica Belgica, 56 (3), 146-54. doi:10.1179/acb.2001.024

Langouet, A.-M., Brice, P., Simon, D., Bocaccio, C., Munck, J. N., Fillet, G., Peny, A.-M., Salles, G., Quesnel, B., Lefrere, F., Reyes, F., & Gisselbrecht, C. (2001). Factors affecting hematopoietic recovery after autologous peripheral blood progenitof-cell transplantation in aggressive non-Hodgkin's lymphoma : a prospective study of 123 patients. Hematology Journal, 2, 81-86. doi:10.1038/sj.thj.6200081

Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442

Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18.

Sylvestre, R.-M., Jerusalem, G., Sautois, B., Beguin, Y., & Fillet, G. (2001). Nouvelles approches thérapeutiques puor l'hypernéphrome métastasique. Médecine et Hygiène, 59, 1607-1609.

Lechanteur, C., Delvenne, P., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J., Merville, M.-P., & Bours, V. (September 2000). Combined Suicide and Cytokine Gene Therapy for Peritoneal Carcinomatosis. Gut, 47 (3), 343-8. doi:10.1136/gut.47.3.343

Baron, F., Gothot, A., Salmon, J., Hermanne, J. P., Pierard, G., Fillet, G., & Beguin, Y. (2000). Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. British Journal of Haematology, 111 (3), 745-53. doi:10.1046/j.1365-2141.2000.02470.x

Bentires-Alj, M., Hellin, A.-C., Lechanteur, C., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J.-L., Merville, M.-P., & Bours, V. (January 2000). Cytosine Deaminase Suicide Gene Therapy for Peritoneal Carcinomatosis. Cancer Gene Therapy, 7 (1), 20-6. doi:10.1038/sj.cgt.7700093

Bonnet, C., Jerusalem, G., Bours, V., & Fillet, G. (2000). Approches thérapeutiques du cancer ovarien. Médecine et Hygiène, 58, 1625-1628.

Frere, P., Canivet, J.-L., Gennigens, C., Rebeix, J. P., Fillet, G., & Beguin, Y. (2000). Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplantation, 26 (3), 343-5. doi:10.1038/sj.bmt.1702485

Mattson, K., Vansteenkiste, J., Stupp, R., Bargetzi, M., Saarinen, A., Jekunen, A., Fillet, G., Teixeira, M., Gatzemeier, U., Olivares, R., Soussan-Lazard, K., & Berille, J. (2000). Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer. Anti-Cancer Drugs, 11, 7-13. doi:10.1097/00001813-200001000-00002

Sautois, B., Scerbo, F., Beguin, Y., & Fillet, G. (2000). Traitement des myélomes réfractaires par la Thalidomide. Médecine et Hygiène, 58, 1633-1634.

Archimbaud, E., Jehn, U., Thomas, X., De Cataldo, F., Fillet, G., Belhabri, A., Peaud, P.-Y., Martin, C., Amadori, S., & Willemze, R. (1999). Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia. Leukemia, 13, 843-849. doi:10.1038/sj.leu.2401445

Herens, C., Hermanne, J.-P., Tassin, F., Fassotte, M.-F., Thiry, A., Jamar, M., Schaaf-Lafontaine, N., Fillet, G., & Koulischer, L. (1999). Translocation (2;3)(p21;q26) as the sole anomaly in a case of primary myelofibrosis. Cancer Genetics and Cytogenetics, 110 (1), 62-4. doi:10.1016/S0165-4608(98)00186-1

Jerusalem, G., Bours, V., & Fillet, G. (1999). Actualités thérapeutiques dans le traitement du cancer colorectal. Médecine et Hygiène, 57, 1552-1554.

Jerusalem, G., Warland, V., Najjar, F., Paulus, P., Fassotte, M. F., Fillet, G., & Rigo, P. (January 1999). Whole-Body 18f-Fdg Pet for the Evaluation of Patients with Hodgkin's Disease and Non-Hodgkin's Lymphoma. Nuclear Medicine Communications, 20 (1), 13-20. doi:10.1097/00006231-199901000-00004

Najjar, F., Jerusalem, G., Paulus, P., Fillet, G., & Rigo, P. (1999). Intérêt clinique de la tomographie à émission de positons dans la détection et le bilan d'extension des lymphomes non Hodgkiniens de malignité intermédiaire ou élevée. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 23, 281-290.

Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x

Van Cutsem, E., Cunningham, D., Ten Bokkel Huinink, W. W., Punt, C. J. A., Alexopoulos, C. G., Dirix, L., Symann, M., Blijham, G. H., Cholet, P., Fillet, G., Van Groeningen, C., Vannetzel, J. M., Levi, F., Panagos, G., Unger, C., Wils, J., Cote, C., Blanc, C., Hérait, P., & Bleiberg, H. (1999). Clinical Activity and Benefit of Irinotecan (CPT-11) in Patients with Colorectal Cancer Truly Resistant to 5-Fluorouracil (5-FU). European Journal of Cancer, 35, 54-59. doi:10.1016/S0959-8049(98)00353-0

Princen, F., Lechanteur, C., Lopez Y Cadenas, M., Rocoux, G., Detroz, B., Gielen, J.-L., Fillet, G., Merville, M.-P., & Bours, V. (August 1998). Repeated Cycles of Retrovirus-Mediated Hsvtk Gene Transfer Plus Ganciclovir Increase Survival of Rats with Peritoneal Carcinomatosis. Gene Therapy, 5 (8), 1054-60. doi:10.1038/sj.gt.3300710

Tassin, F., Hermanne, J.-P., Schaaf-Lafontaine, N., Herens, C., Thiry, A., Paulus, J.-M., Boniver, J., & Fillet, G. (June 1998). Les syndromes myélodysplasiques: syndromes préleucémiques. Revue Médicale de Liège, 53 (6), 357-62.

Baron, F., Hermanne, J.-P., Dowlati, A., Weber, T., Thiry, A., Fassotte, M.-F., Fillet, G., & Beguin, Y. (1998). Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21 (9), 951-4. doi:10.1038/sj.bmt.1701198

Beguin, Y., Baron, F., & Fillet, G. (1998). Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. Haematologica, 83 (12), 1076-81.

Lechanteur, C., Princen, F., Lo Bue, S., Detroz, B., Fillet, G., Gielen, J., Bours, V., & Merville, M.-P. (1998). Hsv-1 Thymidine Kinase Gene Therapy for Peritoneal Carcinomatosis. Advances in Experimental Medicine and Biology, 451, 115-9. doi:10.1007/978-1-4615-5357-1_18

Löwenberg, B., Suciu, S., Archimbaud, E., Haak, H., Stryckmans, P., De Cataldo, R., Dekker, A. W., Berneman, Z. N., Thyss, A., van der Lelie, J., Sonneveld, P., Visani, G., Fillet, G., Hayat, M., Hagemeijer, A., Solbu, G., & Zittoun, R. (1998). Mitoxantrone Versus Daunorubicin in Induction-Consolidation Chemotherapy - The Value of Low-Dose Cytarabine for Maintenance of Remission, and an Assessment of Prognostic Factors in Acute Myeloid Leukemia in the Elderly : Final Report of the Leukemia Cooperative Group of the European Organization for the Research and Treatment of Cancer and th Dutch-Belgian Hemato-Oncology Cooperative Hovon Group Randomized Phase III Study AML-9. Journal of Clinical Oncology, 16, 872-881. doi:10.1200/JCO.1998.16.3.872

Pierard, G., Nikkels, N., Nikkels, A., Arrese Estrada, J., Pierard, C., Jerusalem, G., Beguin, Y., & Fillet, G. (1998). Epidermal Calprotectin Expression in Lymphocyte-Depleted Cutaneous Graft-versus-Host Reaction. Archivos Argentinos de Dermatologia, 48, 139-142.

Beguin, Y., Sautois, B., Forget, P., Bury, J., & Fillet, G. (1997). Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen. Cancer, 79 (7), 1351-4. doi:10.1002/(SICI)1097-0142(19970401)79:7<1351::AID-CNCR12>3.0.CO;2-Z

Jerusalem, G., & Fillet, G. (1997). Les taxanes : un nouvelle classe d'agents cytotoxiques. Médecine et Hygiène, 55, 1501-1504.

Sautois, B., Fillet, G., & Beguin, Y. (1997). Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Experimental Hematology, 25 (2), 103-8.

Archimbaud, E., Jehn, U., De Cataldo, F., Fillet, G., Amadori, S., & Willemze, R. (1996). Autologous stem cell transplantations in elderly AML patients. Trends in Onco-Hematology, 4 (2), 28-29.

Fillet, G. (1996). Maladie de Hodgkin et facteurs de croissance. Tempo Médical, 166, 75-77.

Hermanne, J.-P., TASSIN, F., Beguin, Y., & Fillet, G. (1996). Actualités thérapeutiques dans la thrombocytémie essentielle. Médecine et Hygiène, 54, 1487-1489.

Hermanne, J.-P., TASSIN, F., Bours, V., & Fillet, G. (1996). Intérêt de l'acide rétinoïque "tous trans" dans le traitement de la leucémie aiguë promyélocytaire. Médecine et Hygiène, 54, 1472-1479.

Hermine, O., Haioun, C., Lepage, E., D'Agay, M.-F., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J.-P., Diebold, J., Reyes, F., & Gaulard, P. (1996). Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodkin's Lymphoma. Blood. doi:10.1182/blood.v87.1.265.bloodjournal871265

Jerusalem, G., Detroz, B., Herman, P., Dohogne, A., Closon, M. T., Jacquet, N., Honoré, P., Bruyninx, L., Fillet, G., Fassotte, M.-F., Bours, V., & Lipcsei, G. (1995). Approche thérapeutique du cancer épithélial de l'ovaire au CHU Sart Tilman : Conclusions de la réunion interdisciplinaire du 22 mars 1995. Revue Médicale de Liège, 50, 469-471.

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., & Fillet, G. (1994). Significance of soluble transferrin receptor. Molecular Biology of Hematopoiesis, 451-464.

Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217).

Beguin, Y., Clemons, G. K., Pootrakul, P., & Fillet, G. (1993). Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood, 81 (4), 1067-76. doi:10.1182/blood.v81.4.1067.1067

Fillet, G., & Beguin, Y. (1992). Iron availability for erythropoiesis. In C. Drewienkiewicz, The potential use of erythropoietin to diminish the need for homologous blood in surgery (pp. 43-49). Medical Action Communication.

Beguin, Y., Clemons, G. K., Oris, R., & Fillet, G. (1991). Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood, 77 (4), 868-73. doi:10.1182/blood.v77.4.868.bloodjournal774868

Beguin, Y., & Fillet, G. (1991). Erythropoïétine : utilisation diagnostique et thérapeutique. Revue de l'Association Belge des Technologues de Laboratoire, 18 (3), 161-168.

Beguin, Y., Lipscei, G., Thoumsin, H., & Fillet, G. (1991). Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood, 78 (1), 89-93. doi:10.1182/blood.v78.1.89.89

Beguin, Y., Loo, M., & Fillet, G. (1991). Le dosage du récepteur circulant de la transferringe : une nouveauté pour quantifier l'érythropoïèse. Médecine et Hygiène, 49, 2041-2045.

Beguin, Y., Sautois, B., & Fillet, G. (1991). Perspectives diagnostiques et thérapeutiques de l'érythropoïétine. Médecine et Hygiène, 49, 2034-2045.

Collignon, J., Laurent, C., Rombout, S., & Fillet, G. (1991). L'examen cytogénétique en onco-hématologie : son importance dans la stratégie thérapeutique. Médecine et Hygiène, 49, 3411-3417.

Grek, V., Andrien, F., Collignon, J., & Fillet, G. (1991). Allergic cross-reaction of teicoplanin and vancomycin. Journal of Antimicrobial Chemotherapy, 28, 476-477. doi:10.1093/jac/28.3.476

Sautois, B., Mélon, P., Grek, V., Fassotte, M.-F., & Fillet, G. (1991). Thrombocytopénie allergique à la nitrofurantoïne. Revue Médicale de Liège, 46, 592.

Andrien, F., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1990). Traitement des lymphomes non hodgkiniens : de l'abstention thérapeutique à la greffe de moelle. Médecine et Hygiène, 48, 3672-3676.

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., & Fillet, G. (1990). Relationship of serum selenium to tumor activity in acute non lymphocytic leukemia (ANLL) and chronic lymohocytic leukemia (CLL). Metal ions in Biology and Medecine, 500-502.

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., Fillet, G., & Weber, G. (1990). Use of PIXE to measure serum copper, zinc, selenium, and bromine in patients with hematologic malignancies. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B49, 202-204. doi:10.1016/0168-583X(90)90243-N

Fassotte, M.-F., Beguin, Y., Andrien, F., & Fillet, G. (1990). Allogreffes et autogreffes de moelle osseuse. Indications, résultats, perspectives. Médecine et Hygiène, 48, 3666-3671.

Triffaux, H., & Fillet, G. (1990). Rôle du volume globulaire moyen dans le diagnostic de l'anémie. Actualité Médicale Belge, 275, 8-9.

Dokekias, A. E., Croisiaux, C., Andrien, F., Andre, C., Trotteur, G., Henrivaux, P., Gaspard, U., Rorive, G., & Fillet, G. (1989). Purpura thrombotique thrombocytopénique. Revue Médicale de Liège, 44, 601-609.

Fillet, G., Baldelli, L., & BEGUIN, Y. (1989). Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood, 74 (2), 844-51. doi:10.1182/blood.v74.2.844.bloodjournal742844

Bonnet, P., de Leval, J., Fillet, G., & Golaire, M. C. (1988). Plasmocytome solitaire de l'urètre. Acta Urologica Belgica, 51, 81-85.

Bury, J., Salmon, J., & Fillet, G. (1988). Gammapathie monoclonale d'origine indéterminée et myélome. Revue Médicale de Liège, 43, 270-274.

Andrien, F., Duvivier, A., Bury, J., Lemaire, M., Thiry, A., Boniver, J., & Fillet, G. (1987). Traitement des lymphomes non hodgkiniens. Revue Médicale de Liège, 42, 516-522.

Beguin, Y., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (1987). Correlation of serum trace elements with other biological parameters in hemoproliferative disorders. Trace element analytical chemistry in medicine and biology, 4, 537-545.

Beguin, Y., Weber, G., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., & Fillet, G. (1987). Dosage du zinc sérique chez des patients atteints de leucémie aiguë. In A. Favier, J. Arnaud, ... H. Faure, Le zinc en médecine et biologie (pp. 224-226). Paris, France: Editions Médicales Internationales.

Fillet, G. (1987). Hématotoxicité médicamenteuse. Revue Médicale de Liège, 42, 919-920.

Fillet, G., Bury, J., & Baudrihaye, M. (1987). Allogreffes et autogreffes de moelle osseuse. Principes et indications. Revue Médicale de Liège, 42, 503-509.

Andrien, F., Lemaire, M., Beguin, Y., Bury, J., Closon, J., David, J.-L., Dejardin-Closon, M.-T., Duvivier, A., Fillet, G., & Tjean, M. (1986). Second tumors and myeloproliferative diseases after Hodgkin's disease treatment. Leukemia Research, 10, 887.

Fillet, G., & Bury, J. (1986). Cancers hématologiques et qualité de vie. Revue Médicale de Liège, 41, 673-674.

Ludwig, H., Cortelezzi, A., Scheithauer, W., Van Camp, B. G. K., Kuzmits, R., Fillet, G., Peetermans, M., Polli, E., & Flener, R. (1986). Recombinant Interferon alfa-2c versus polychemotherapy (VMCP) for treatment of multiple myeloma : a prospective randomized trial. European Journal of Cancer and Clinical Oncology, 22, 1111-1116. doi:10.1016/0277-5379(86)90015-5

Beguin, Y., Detroz, B., Defraigne, J.-O., Bury, J., Boniver, J., Fillet, G., & Lejeune, G. (1985). Solitary plasmacytoma of the thyroid with serum monoclonal IgG. In J. Radl, W. Hijmans, ... B. Van Camp, Monoclonal gammopathies. Clinical significance and basic mechanisms (pp. 251-253). Eurage.

Lubrano, D., Helias, P., Bach, P., Leclercq, M., Fillet, G., Lecomte, J., & Damas, J. (1985). Un cas d'envenimation mortelle avec hyperfibrinolyse par piqûre multiples de guêpes (Vespa Crabro L.). Revue Médicale de Liège, 40, 844-846.

Malherbe, R., Bury, J., Fillet, G., Andrien, J.-M., & Borlee, M. (1985). Etude de cinq cas de leucémie à tricholeucocyte. Revue Médicale de Liège, 40, 586-592.

André, C., Bury, J., Fillet, G., & Moonen, G. (1984). Une complication rare du zona ophtalmique : l'artérite cérébrale de propagation. Acta Clinica Belgica, 39, 159-162.

Fillet, G. (1984). Les leucémies - Chronique interuniversitaire. Revue Médicale de Liège, 39, 781-787.

Fillet, G. (1984). Les leucémies - Chronique interuniversitaire. Louvain Medical, 103, 437-445.

Fillet, G. (1984). Agranulocytose médicamenteuse. Médecine et Hygiène, 42, 2533-2541.

Bury, J., & Fillet, G. (1983). Ciclosporine et immunosuppression. Applications actuelles. Médecine et Hygiène, 41, 2696-2701.

Fillet, G., & Bury, J. (1983). Système HLA et greffe de moelle osseuse. Revue Médicale de Liège, 38, 135-136.

Henrivaux, P., Bury, J., Demonty, J., & Fillet, G. (1983). Le syndrome d'immunodéficience acquise : espoirs et limites thérapeutiques. Médecine et Hygiène, 41, 4269-4273.

Bury, J., Fillet, G., Hugues, J., & Nizet, C. (1982). Les signes prémonitoires des hémopathies malignes. Revue Médicale de Liège, 37, 293-296.

Fillet, G. (1982). Les leucémies chroniques. Aspects cliniques et thérapeutiques. Actualité Médicale Belge, 9, 14-15.

Fillet, G., & Bury, J. (1982). Thérapeutique antivirale systémique : vidarabine et acyclovir. Médecine et Hygiène, 40, 2729-2734.

Fillet, G., Desoignies, J., Jardon-Jeghers, C., & Boniver, J. (1982). Lymphome centrocytique-centroblastique ou est-il bon, est-il méchant ? Revue Médicale de Liège.

Tjean, M., Bury, J., & Fillet, G. (1982). La vidarabine : un traitement antiherpétique actif par voie parentérale. Revue Médicale de Liège, 37, 82-85.

Delvaux, D., Andrien, J.-M., & Fillet, G. (1981). Le traitement par chélateurs de l'hémochromatose post-transfusionnelle. Revue Médicale de Liège, 36, 477-479.

Fillet, G. (1980). Les fièvres prolongées d'origine néoplasique. Revue Médicale de Liège, 35, 190-193.

Fillet, G. (1980). Diagnostic et traitement des maladies de surcharge en fer. Médecine et Hygiène, 38, 2662-2667.

Radermecker, M., Bruwier, M., Bury, J., & Fillet, G. (1980). P1 incompatibility in pigeon breeders. Clinical Allergy, 10, 309-312. doi:10.1111/j.1365-2222.1980.tb02112.x

Fillet, G. (1978). Le myélome. Revue Médicale de Liège, 33, 354-364.

Fillet, G. (1978). Le cycle du fer. Physiopathologie et exploration. Annales Médico-chirurgicales du Hainaut, 30, 247-259.

Fillet, G., Andrien, J.-M., & Bury, J. (1977). Effects of transfusion on serum iron, serum lactate dehydrogenase and platelets in megaloblastic anemia. American Journal of Clinical Pathology, 68, 458-462. doi:10.1093/ajcp/68.4.458

Andrien, J.-M., Bury, J., Fillet, G., Hugues, J., & Paulus, J.-M. (1975). Diagnostic et traitement des anémies. Revue Médicale de Liège, 30, 285-294.

Fillet, G., Cook, J.-D., & Finch, C. A. (1974). Storage Iron Kinetics. VII. A biologic Model for Reticulo-Endothelial Iron Transport. Journal of Clinical Investigation, 53, 1527-1533.

Cook, J. D., Barry, W. E., Hershko, C., Fillet, G., & Finch, C. A. (1973). Iron Kinetics with emphasis on Iron overload. American Journal of Pathology, 72, 337-343.

Fillet, G. (1972). Utilisation en scintillation liquide du Triton X-100 pour le comptage à haut rendement du radiofer plasmatique. Pathologie Biologie, 20, 227-230.

Biver, A., Fillet, G., & Demelenne, A. (1971). Une étude des staphylocoques coagulase positifs isolés à partir de grands brûlés. Acta Chirurgica Belgica, 70 (8), 696-711.

de Leval, M., Fourny, J., Fillet, G., & Honoré, D. (1971). Haematological modifications in counterpulsation. Cardiovascular Surgery, 12, 210-217.

Fillet, G., & Paulus, J.-M. (1971). Tests isotopiques en Hématologie. Revue Médicale de Liège, 26 (5), 156-166.

Fillet, G., Hanquet, M., & Castermans, A. (1969). A study of Staphylococcus Aureus infection in burns. Verbrennungskrankheit Fortschritte in Klinik und Forschung, 171-177.

Paulus, J.-M., Fillet, G., Thompson, K., & Willems, J. (1969). Interprétation mathématique de l'étude de la durée de vie des plaquettes marquées au chrome radio-actif. Nouvelle Revue Française d'Hématologie, 9 (6), 886-888.

Fillet, G. (1968). Anémie ferriprive - Métabolisme du fer - Traitement martial. Revue d'enseignement post-universitaire de la Société de Médecine de Charleroi, 58-61.